Annual Net Margin
-65.46%
+8.19%+11.12%
December 1, 2023
Summary
- As of March 1, 2025, NBY annual net profit margin is -65.46%, with the most recent change of +8.19% (+11.12%) on December 1, 2023.
- During the last 3 years, NBY annual net margin has risen by +45.66% (+41.09%).
- NBY annual net margin is now -480.58% below its all-time high of 17.20%, reached on December 31, 2009.
Performance
NBY Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
-49.65%
+16.39%+24.82%
September 1, 2024
Summary
- As of March 1, 2025, NBY quarterly net profit margin is -49.65%, with the most recent change of +16.39% (+24.82%) on September 1, 2024.
- Over the past year, NBY quarterly net margin has increased by +21.17% (+29.89%).
- NBY quarterly net margin is now -208.93% below its all-time high of 45.58%, reached on December 31, 2009.
Performance
NBY Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
NBY Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +11.1% | +29.9% |
| 3 y3 years | +41.1% | +13.8% |
| 5 y5 years | -25.1% | +13.8% |
NBY Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.7% | +11.1% | -1364.6% | +78.0% |
| 5 y | 5-year | -14.7% | +55.3% | -1364.6% | +78.0% |
| alltime | all time | -480.6% | +95.5% | -208.9% | +98.2% |
NovaBay Pharmaceuticals Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -49.65%(-24.8%) |
| Jun 2024 | - | -66.04%(-45.9%) |
| Mar 2024 | - | -122.16%(+89.5%) |
| Dec 2023 | -65.46%(-11.1%) | -64.47%(-9.0%) |
| Sep 2023 | - | -70.82%(+22.9%) |
| Jun 2023 | - | -57.61%(-22.5%) |
| Mar 2023 | - | -74.35%(-67.0%) |
| Dec 2022 | -73.65%(+29.0%) | -225.25%(+6245.1%) |
| Sep 2022 | - | -3.55%(-94.0%) |
| Jun 2022 | - | -58.85%(+1636.0%) |
| Mar 2022 | - | -3.39%(-31.9%) |
| Dec 2021 | -57.08%(-48.6%) | -4.98%(-95.1%) |
| Sep 2021 | - | -101.06%(+16.0%) |
| Jun 2021 | - | -87.15%(+3.7%) |
| Mar 2021 | - | -84.01%(-9.6%) |
| Dec 2020 | -111.12%(-24.1%) | -92.90%(-37.4%) |
| Sep 2020 | - | -148.43%(+31.9%) |
| Jun 2020 | - | -112.50%(+34.5%) |
| Mar 2020 | - | -83.62%(-47.0%) |
| Dec 2019 | -146.36%(+179.7%) | -157.63%(+802.8%) |
| Sep 2019 | - | -17.46%(-87.5%) |
| Jun 2019 | - | -139.80%(-50.2%) |
| Mar 2019 | - | -280.95%(+703.2%) |
| Dec 2018 | -52.33%(+28.9%) | -34.98%(-28.5%) |
| Sep 2018 | - | -48.95%(-13.9%) |
| Jun 2018 | - | -56.87%(-22.1%) |
| Mar 2018 | - | -72.96%(-680.9%) |
| Dec 2017 | -40.61%(-63.3%) | 12.56%(-121.0%) |
| Sep 2017 | - | -59.81%(+41.9%) |
| Jun 2017 | - | -42.16%(-61.1%) |
| Mar 2017 | - | -108.38%(+168.1%) |
| Dec 2016 | -110.54%(-74.5%) | -40.42%(-62.8%) |
| Sep 2016 | - | -108.67%(+7.6%) |
| Jun 2016 | - | -101.01%(-65.8%) |
| Mar 2016 | - | -295.35%(+14.9%) |
| Dec 2015 | -433.07% | -257.13%(-41.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | -436.83%(-9.9%) |
| Jun 2015 | - | -484.82%(-43.8%) |
| Mar 2015 | - | -862.45%(-5.2%) |
| Dec 2014 | -1441.56%(+212.5%) | -909.98%(-67.2%) |
| Sep 2014 | - | -2775.66%(+16.0%) |
| Jun 2014 | - | -2391.87%(+93.2%) |
| Mar 2014 | - | -1237.85%(+52.6%) |
| Dec 2013 | -461.37%(+356.1%) | -811.18%(+131.7%) |
| Sep 2013 | - | -350.14%(-26.7%) |
| Jun 2013 | - | -477.36%(+21.5%) |
| Mar 2013 | - | -393.04%(+86.2%) |
| Dec 2012 | -101.15%(+119.2%) | -211.14%(-9697.3%) |
| Sep 2012 | - | 2.20%(-100.9%) |
| Jun 2012 | - | -255.57%(+33.3%) |
| Mar 2012 | - | -191.74%(-35.0%) |
| Dec 2011 | -46.15%(+4.5%) | -294.96%(-7821.5%) |
| Sep 2011 | - | 3.82%(-59.3%) |
| Jun 2011 | - | 9.39%(-111.8%) |
| Mar 2011 | - | -79.84%(-1606.4%) |
| Dec 2010 | -44.17%(-356.8%) | 5.30%(-106.7%) |
| Sep 2010 | - | -78.72%(+67.4%) |
| Jun 2010 | - | -47.02%(-39.8%) |
| Mar 2010 | - | -78.17%(-271.5%) |
| Dec 2009 | 17.20%(-114.2%) | 45.58%(-1425.0%) |
| Sep 2009 | - | -3.44%(-71.9%) |
| Jun 2009 | - | -12.26%(+0.7%) |
| Mar 2009 | - | -12.18%(-82.6%) |
| Dec 2008 | -120.71%(+32.2%) | -69.95%(-25.2%) |
| Sep 2008 | - | -93.53%(-44.0%) |
| Jun 2008 | - | -167.13%(-6.9%) |
| Mar 2008 | - | -179.49%(+95.8%) |
| Dec 2007 | -91.32%(-73.5%) | -91.65%(-14.9%) |
| Sep 2007 | - | -107.76%(+1.4%) |
| Jun 2007 | - | -106.28%(+76.5%) |
| Mar 2007 | - | -60.22%(-33.6%) |
| Dec 2006 | -344.81% | -90.64%(-86.3%) |
| Sep 2006 | - | -660.58% |
FAQ
- What is NovaBay Pharmaceuticals annual net profit margin?
- What is the all time high annual net margin for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual net margin year-on-year change?
- What is NovaBay Pharmaceuticals quarterly net profit margin?
- What is the all time high quarterly net margin for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly net margin year-on-year change?
What is NovaBay Pharmaceuticals annual net profit margin?
The current annual net margin of NBY is -65.46%
What is the all time high annual net margin for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual net profit margin is 17.20%
What is NovaBay Pharmaceuticals annual net margin year-on-year change?
Over the past year, NBY annual net profit margin has changed by +8.19% (+11.12%)
What is NovaBay Pharmaceuticals quarterly net profit margin?
The current quarterly net margin of NBY is -49.65%
What is the all time high quarterly net margin for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly net profit margin is 45.58%
What is NovaBay Pharmaceuticals quarterly net margin year-on-year change?
Over the past year, NBY quarterly net profit margin has changed by +21.17% (+29.89%)